These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naïve patients from Southern Brazil. Santos AF; Silveira J; Muniz CP; Tornatore M; Góes LR; Mendoza-Sassi RA; Martinez AM; Tupinambás U; Greco DB; Soares MA J Clin Virol; 2011 Dec; 52(4):373-6. PubMed ID: 21975076 [TBL] [Abstract][Full Text] [Related]
23. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance. Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R; Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705 [TBL] [Abstract][Full Text] [Related]
24. Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes. de Mendoza C; Rodriguez C; Corral A; del Romero J; Gallego O; Soriano V Clin Infect Dis; 2004 Oct; 39(8):1231-8. PubMed ID: 15486849 [TBL] [Abstract][Full Text] [Related]
25. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887 [TBL] [Abstract][Full Text] [Related]
26. Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil. Varella RB; Ferreira SB; de Castro MB; Zalis MG; Tavares MD J Med Virol; 2007 Aug; 79(8):1033-9. PubMed ID: 17596836 [TBL] [Abstract][Full Text] [Related]
27. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients. Jullaksorn D; Boonchawalit S; Uttiyoung J; Soonthornsata B; Yowang A; Krathong N; Chautrakul S; Ikuta K; Roobsoong A; Kanitvittaya S; Sawanpanyalert P; Kameoka M Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518 [TBL] [Abstract][Full Text] [Related]
28. HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection. Manosuthi W; Thongyen S; Nilkamhang S; Manosuthi S; Sungkanuparph S J Med Virol; 2013 Feb; 85(2):194-9. PubMed ID: 23161095 [TBL] [Abstract][Full Text] [Related]
29. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso. Nadembega WM; Giannella S; Simpore J; Ceccherini-Silberstein F; Pietra V; Bertoli A; Pignatelli S; Bellocchi MC; Nikiema JB; Cappelli G; Bere A; Colizzi V; Perno CP; Musumeci S J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878 [TBL] [Abstract][Full Text] [Related]
31. Characterization of protease resistance-associated mutations in HIV type 1 drug-naive patients following the increasing prevalence of the CRF02_AG strain in Morocco. Miri L; Ouladlahsen A; Kettani A; Bensghir R; Marhoum Elfilali K; Wakrim L AIDS Res Hum Retroviruses; 2012 Jun; 28(6):571-7. PubMed ID: 22145994 [TBL] [Abstract][Full Text] [Related]
32. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy. Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750 [TBL] [Abstract][Full Text] [Related]
33. Primary drug resistance in antiretroviral-naïve injection drug users. Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493 [TBL] [Abstract][Full Text] [Related]
34. Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union. Vázquez de Parga E; Rakhmanova A; Pérez-Alvarez L; Vinogradova A; Delgado E; Thomson MM; Casado G; Sierra M; Muñoz M; Carmona R; Vega Y; Contreras G; Medrano L; Osmanov S; Nájera R J Med Virol; 2005 Nov; 77(3):337-44. PubMed ID: 16173024 [TBL] [Abstract][Full Text] [Related]
35. Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy. Santoro MM; Svicher V; Gori C; Zaccarelli M; Tozzi V; Forbici F; D'Arrigo R; Trotta MP; Bellocchi MC; Visco-Comandini U; Cenci A; Bertoli A; Narciso P; Antinori A; Perno CF; Ceccherini-Silberstein F New Microbiol; 2006 Apr; 29(2):89-100. PubMed ID: 16841549 [TBL] [Abstract][Full Text] [Related]
36. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil. Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934 [TBL] [Abstract][Full Text] [Related]
37. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198 [TBL] [Abstract][Full Text] [Related]
38. Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006. Derache A; Maiga AI; Traore O; Akonde A; Cisse M; Jarrousse B; Koita V; Diarra B; Carcelain G; Barin F; Pizzocolo C; Pizarro L; Katlama C; Calvez V; Marcelin AG J Antimicrob Chemother; 2008 Sep; 62(3):456-63. PubMed ID: 18556706 [TBL] [Abstract][Full Text] [Related]